{"DataElement":{"publicId":"3173974","version":"1","preferredName":"Adjacent Hepatic Tissue Inflammation Extent Type","preferredDefinition":"Text term that represents the extent of active hepatic inflammation in adjacent tissue.","longName":"3173971v1.0:3173973v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3173971","version":"1","preferredName":"Adjacent Hepatic Tissue Inflammation","preferredDefinition":"Next to or adjoining._The tissue of the liver. It includes the hepatic lobules, hepatic sinusoids, perisinusoidal spaces, and portal triad. The hepatic lobules are composed of hepatocytes._A localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation. --2004","longName":"3173969v1.0:2547406v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3173969","version":"1","preferredName":"Adjacent Hepatic Tissue","preferredDefinition":"Next to or adjoining.:The tissue of the liver. It includes the hepatic lobules, hepatic sinusoids, perisinusoidal spaces, and portal triad. The hepatic lobules are composed of hepatocytes.","longName":"C25408:C32735","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adjacent","conceptCode":"C25408","definition":"Next to or adjoining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hepatic Tissue","conceptCode":"C32735","definition":"The tissue of the liver. It includes the hepatic lobules, hepatic sinusoids, perisinusoidal spaces, and portal triad. The hepatic lobules are composed of hepatocytes.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97EFE7BF-390D-DFE9-E040-BB89AD4369C7","latestVersionIndicator":"Yes","beginDate":"2010-12-21","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-21","modifiedBy":"ONEDATA","dateModified":"2010-12-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2547406","version":"1","preferredName":"Inflammation","preferredDefinition":"A localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation. --2004","longName":"C3137","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"233D63FC-80B8-3268-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-27","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-11-27","modifiedBy":"ONEDATA","dateModified":"2006-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"97EFE7BF-391B-DFE9-E040-BB89AD4369C7","latestVersionIndicator":"Yes","beginDate":"2010-12-21","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 12/2010 sw Reviewed metadata and released 7/29/11 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3173973","version":"1","preferredName":"Inflammation Extent Type","preferredDefinition":"A localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation. --2004_The range, magnitude, or distance over which a thing spans an interval of distance, space, or time._Type; a subdivision of a particular kind of thing.","longName":"3173973v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97EFE7BF-395B-DFE9-E040-BB89AD4369C7","beginDate":"2010-12-21","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-21","modifiedBy":"ONEDATA","dateModified":"2010-12-21","deletedIndicator":"No"},{"value":"Mild","valueDescription":"Mild","ValueMeaning":{"publicId":"2563414","version":"1","preferredName":"Mild","longName":"2563414","preferredDefinition":"Not severe or strong; far from extreme; not serious enough to endanger life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mild","conceptCode":"C70666","definition":"Gentle or temperate in nature or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C4C3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"COOPERM","dateModified":"2008-10-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97EFE7BF-3965-DFE9-E040-BB89AD4369C7","beginDate":"2010-12-21","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-21","modifiedBy":"ONEDATA","dateModified":"2010-12-21","deletedIndicator":"No"},{"value":"Severe","valueDescription":"Severe","ValueMeaning":{"publicId":"2842706","version":"1","preferredName":"Severe","longName":"2842706","preferredDefinition":"Intensely or extremely bad or unpleasant in degree, quality, or extent; life threatening.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe","conceptCode":"C70667","definition":"Intensely bad or unpleasant in degree, quality or extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63E8BE48-D662-6137-E040-BB89AD434B93","latestVersionIndicator":"Yes","beginDate":"2009-02-27","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-02-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97EFE7BF-396F-DFE9-E040-BB89AD4369C7","beginDate":"2010-12-21","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-21","modifiedBy":"ONEDATA","dateModified":"2010-12-21","deletedIndicator":"No"},{"value":"None","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"97EFE7BF-3979-DFE9-E040-BB89AD4369C7","beginDate":"2010-12-21","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-21","modifiedBy":"ONEDATA","dateModified":"2010-12-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3173972","version":"1","preferredName":"Inflammation Extent Type","preferredDefinition":"A localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation. --2004:The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.:Type; a subdivision of a particular kind of thing.","longName":"C3137:C25332:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Extent","conceptCode":"C25332","definition":"The range, magnitude, or distance over which a thing spans an interval of distance, space, or time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97EFE7BF-3932-DFE9-E040-BB89AD4369C7","latestVersionIndicator":"Yes","beginDate":"2010-12-21","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-21","modifiedBy":"ONEDATA","dateModified":"2010-12-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"97EFE7BF-3943-DFE9-E040-BB89AD4369C7","latestVersionIndicator":"Yes","beginDate":"2010-12-21","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-21","modifiedBy":"MAESKEB","dateModified":"2011-11-11","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 12/2010 sw Reviewed metadata and released 7/29/11 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[{"name":"adjacent_hepatic_tissue_inflammation_extent_type","type":"TCGA_XML_Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"Evidence of Active Hepatic In","type":"Preferred Question Text","description":"Evidence of Active Hepatic Inflammation in Adjacent Tissue","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"97F088B7-A729-1AC7-E040-BB89AD432F3A","latestVersionIndicator":"Yes","beginDate":"2010-12-21","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-21","modifiedBy":"TSESU","dateModified":"2018-07-13","changeDescription":"Released per approval from T.Lichtenberg. mc 7/29/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}